These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9513721

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.
    Cancer Res; 2007 Sep 15; 67(18):8671-81. PubMed ID: 17875707
    [Abstract] [Full Text] [Related]

  • 23. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.
    Bradbury JM, Arno J, Edwards PA.
    Oncogene; 1993 Jun 15; 8(6):1551-8. PubMed ID: 8099220
    [Abstract] [Full Text] [Related]

  • 24. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.
    Exp Mol Pathol; 2001 Jun 15; 70(3):183-93. PubMed ID: 11417997
    [Abstract] [Full Text] [Related]

  • 25. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL.
    Cancer Res; 2001 Nov 15; 61(22):8298-305. PubMed ID: 11719463
    [Abstract] [Full Text] [Related]

  • 26. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.
    Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
    Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, Murthy S, Thor AD.
    Cancer Res; 2003 May 15; 63(10):2425-33. PubMed ID: 12750262
    [Abstract] [Full Text] [Related]

  • 30. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA, Troyer KL, Lee DC.
    Oncogene; 2000 Jun 29; 19(28):3193-9. PubMed ID: 10918574
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Transforming growth factor alpha and mouse models of human breast cancer.
    Humphreys RC, Hennighausen L.
    Oncogene; 2000 Feb 21; 19(8):1085-91. PubMed ID: 10713694
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice.
    Freitas I, Fracchiolla S, Baronzio G, Griffini P, Bertone R, Sitar GM, Barni S, Gerzeli G, Sacco MG.
    Anticancer Res; 2003 Feb 21; 23(5A):3783-94. PubMed ID: 14666678
    [Abstract] [Full Text] [Related]

  • 36. MMTV-EGF receptor transgene promotes preneoplastic conversion of multiple steroid hormone-responsive tissues.
    Marozkina NV, Stiefel SM, Frierson HF, Parsons SJ.
    J Cell Biochem; 2008 Apr 15; 103(6):2010-8. PubMed ID: 17960555
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M, Akahane T, Buck T, Yoshiji H, Gomez DE, Schoeffner DJ, Okajima E, Harris SR, Bunce OR, Thorgeirsson SS, Thorgeirsson UP.
    Carcinogenesis; 2004 Sep 15; 25(9):1735-46. PubMed ID: 15166086
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A.
    Cancer Res; 2006 Jun 01; 66(11):5565-73. PubMed ID: 16740691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.